These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 13595256)

  • 1. Neuromuscular and ganglionic blocking action of thiamine and its derivatives.
    DI PALMA JR; HITCHCOCK P
    Anesthesiology; 1958; 19(6):762-9. PubMed ID: 13595256
    [No Abstract]   [Full Text] [Related]  

  • 2. The physiological action of neuromuscular and ganglionic blocking agents.
    BURN JH
    Br J Anaesth; 1957 Jun; 29(6):242-8. PubMed ID: 13436684
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of ganglion blocking agents on metabolic variations].
    GUGLIELMI F; BELSASSO E
    G Ital Anestesiol; 1952; 18(5):530-4. PubMed ID: 13021502
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological characterization of autonomic drugs in tissue metabolism of the salivary gland. I. Spasmolytics and ganglion-blocking agents].
    BROCK N; DRUCKREY H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1954; 223(4):314-31. PubMed ID: 13223808
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on cholinergic-blocking substances. VI. The pharmacology of hexamethonium- and pendiomid type ganglionic-blocking compounds.
    GYERMEK L
    Acta Physiol Acad Sci Hung; 1954; 5(1-2):163-79. PubMed ID: 13147923
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of some newer ganglionic blocking agents on accommodation.
    BLODI FC
    Am J Ophthalmol; 1956 Nov; 42(5):747-51. PubMed ID: 13372697
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of ganglion blocking agents, spasmolytics and novocaine on pharmacologically-induced vomiting reactions].
    BUSSE W; LENDLE L
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 218(3):169-76. PubMed ID: 13087349
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of certain ganglionic blocking agents on neuromuscular transmission.
    DEACOCK AR; DAVIES TD
    Br J Anaesth; 1958 May; 30(5):217-25. PubMed ID: 13536201
    [No Abstract]   [Full Text] [Related]  

  • 9. The ganglionic blocking activity of a series of 4-aminoethylpiperidine derivatives.
    COLVILLE KI; FANELLI RV
    J Am Pharm Assoc Am Pharm Assoc; 1956 Nov; 45(11):727-9. PubMed ID: 13376360
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of preganglionic denervation on the reactions of ganglion cells.
    PERRY WL; REINERT H
    J Physiol; 1954 Oct; 126(1):101-15. PubMed ID: 13212733
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of ganglionic blocking agents.
    MAINLAND JF; SHAW FH
    Nature; 1952 Sep; 170(4323):418-9. PubMed ID: 12993186
    [No Abstract]   [Full Text] [Related]  

  • 12. Peripheral action of the ganglion blocking agents.
    SHIMAMOTO K; KANAUCHI O; UCHIZUMI S
    Jpn J Pharmacol; 1955 Sep; 5(1):66-76. PubMed ID: 13306412
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-ejaculatory effect of sympatholytic, gangliolytic and spasmolytic drugs.
    LOEWE S; PUTTUCK SL
    J Pharmacol Exp Ther; 1953 Mar; 107(3):379-84. PubMed ID: 13035676
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of the ortho- and parasympathetic paralizing action of some ganglion blocking agents].
    CHAUCHARD P; CHAUCHARD B
    C R Seances Soc Biol Fil; 1952 Apr; 146(7-8):528-9. PubMed ID: 12998143
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of mecamylamine on the action of certain other ganglionic blocking agents.
    PAYNE JP
    Br J Anaesth; 1957 Aug; 29(8):358-62. PubMed ID: 13460132
    [No Abstract]   [Full Text] [Related]  

  • 16. The comparative effects of four ganglionic blocking agents on the cardiovascular system of man.
    WINSOR T
    Am J Med Sci; 1955 Aug; 230(2):133-42. PubMed ID: 14398691
    [No Abstract]   [Full Text] [Related]  

  • 17. [New trends in the treatment of hypertension. II. Experimental investigations on two new Hungarian preparations; hexamethonium, N. 310].
    TARJAN P; CSIPAK Z; BARATH J
    Orv Hetil; 1955 Apr; 96(17):468-71. PubMed ID: 13245212
    [No Abstract]   [Full Text] [Related]  

  • 18. A critical analysis of the criteria for the clinical evaluation of anticholinergic and spasmolytic drugs in gastroenterology.
    BACHRACH WH; ROWEN BR; HALSTED JA; SCHAPIRO H; HOLMSTROM W; PRICE P
    Acta Med Scand Suppl; 1954; 288():1-78. PubMed ID: 13171036
    [No Abstract]   [Full Text] [Related]  

  • 19. The search for selective ganglion blocking drugs for therapeutic use.
    SIMPSON JA
    Glasgow Med J; 1953 Oct; 34(10):447-54. PubMed ID: 13108087
    [No Abstract]   [Full Text] [Related]  

  • 20. Do ganglion-blocking agents and reserpine affect central vasomotor activity?
    McCUBBIN JW; PAGE IH
    Circ Res; 1958 Nov; 6(6):816-24. PubMed ID: 13585611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.